Kathy Oubre Discusses Challenges With PBMs and Payers in the

Kathy Oubre, MS, CEO of Pontchartrain Cancer Center, discusses the use of biosimilars and how pharmacy benefit managers (PBMs) as well as payers have challenged the biosimilar market.

Related Keywords

United States , American , Kathy Oubre , Community Oncology Alliance , Pontchartrain Cancer Center , American Journal , Managed Care , Medicare Advantage , Cpbm , Oncology , Cancer , Medicare , Biosimilars ,